HLA typing in familial renal carcinoma

Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate.

International journal of radiation oncology, biology, physics·2001

Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate.

International journal of radiation oncology, biology, physics·2001

Randomized phase III study comparing Best Supportive Care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97-13.

International journal of radiation oncology, biology, physics·2000

Predicting long-term survival, and the need for hormonal therapy: a meta-analysis of RTOG prostate cancer trials.

International journal of radiation oncology, biology, physics·2000

Four prognostic groups predict long-term survival from prostate cancer following radiotherapy alone on Radiation Therapy Oncology Group clinical trials.

International journal of radiation oncology, biology, physics·2000

Does androgen suppression enhance the efficacy of postoperative irradiation? A secondary analysis of RTOG 85-31. Radiation Therapy Oncology Group.

Urology·1999

Four amino acid exchanges located in the alpha-2 domain specify the novel HLA-B*50:20 allele.

Tissue antigens·2015

A novel HLA-A02 variant, HLA-A02:575, detected in a Taiwanese bone marrow hematopoietic stem cell donor.

Tissue antigens·2015

Identification of a novel HLA-A*02:06:01:02 allele in a Chinese individual by sequence-based typing.

Tissue antigens·2015

Genetic variation of the MHC class II DRB genes in the Japanese weasel, Mustela itatsi, endemic to Japan, compared with the Siberian weasel, Mustela sibirica.

Tissue antigens·2015

Questionable expression of unstable DQ heterodimer containing HLA-DQA1*01:07.

Tissue antigens·2015

Characterization of bovine MHC class II DRB3 diversity in South American Holstein cattle populations.

Tissue antigens·2015

Inclusive designs that allow the inclusion of a broader population in randomized controlled trials: An evaluation of randomization ratio and analysis strategy.

Statistical methods in medical research·2026

A Novel tRNA Half mt-5'-tiRNA-Tyr Promotes Colorectal Cancer Proliferation via Inducing HARS2 Succinylation.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Minimal intervention approach for a lesion suggestive of congenital granular cell epulis: a case report.

General dentistry·2026

Mitochondrial dysfunction‑driven ferroptosis in cerebral ischemia‑reperfusion injury: Mechanisms and therapeutic strategies (Review).

Molecular medicine reports·2026

Clinically Relevant Outcomes With Romiplostim in Patients With Solid Tumors and Persistent Chemotherapy Induced Thrombocytopenia.

American journal of hematology·2026

Related Experiment Videos

HLA typing in familial renal carcinoma

Related Concept Videos

Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate.

Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate.

Randomized phase III study comparing Best Supportive Care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97-13.

Predicting long-term survival, and the need for hormonal therapy: a meta-analysis of RTOG prostate cancer trials.

Four prognostic groups predict long-term survival from prostate cancer following radiotherapy alone on Radiation Therapy Oncology Group clinical trials.

Does androgen suppression enhance the efficacy of postoperative irradiation? A secondary analysis of RTOG 85-31. Radiation Therapy Oncology Group.

Four amino acid exchanges located in the alpha-2 domain specify the novel HLA-B*50:20 allele.

A novel HLA-A02 variant, HLA-A02:575, detected in a Taiwanese bone marrow hematopoietic stem cell donor.

Identification of a novel HLA-A*02:06:01:02 allele in a Chinese individual by sequence-based typing.

Genetic variation of the MHC class II DRB genes in the Japanese weasel, Mustela itatsi, endemic to Japan, compared with the Siberian weasel, Mustela sibirica.

Questionable expression of unstable DQ heterodimer containing HLA-DQA1*01:07.

Characterization of bovine MHC class II DRB3 diversity in South American Holstein cattle populations.

Inclusive designs that allow the inclusion of a broader population in randomized controlled trials: An evaluation of randomization ratio and analysis strategy.

A Novel tRNA Half mt-5'-tiRNA-Tyr Promotes Colorectal Cancer Proliferation via Inducing HARS2 Succinylation.

Minimal intervention approach for a lesion suggestive of congenital granular cell epulis: a case report.

Mitochondrial dysfunction‑driven ferroptosis in cerebral ischemia‑reperfusion injury: Mechanisms and therapeutic strategies (Review).

Clinically Relevant Outcomes With Romiplostim in Patients With Solid Tumors and Persistent Chemotherapy Induced Thrombocytopenia.

Related Experiment Videos

HLA typing in familial renal carcinoma

Related Concept Videos

Related Articles